Friday 6 November 2026 Export MANE’s income statement to Excel — free account

Veradermics Incorporated

MANE Healthcare Biotechnology

Insider buying

138.19 9.59 +7.46%

Follow MANE

Alert me

Market cap: $5.4B
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Valuation Filings

Veradermics Incorporated 10-K filed Mar 30, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed Mar 30, 2026 · accepted 5:35 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 7, Management’s Discussion and Analysis: no comparison — no earlier filing on file